Hiroshima G7 Global Health Task Force 2022–2023 In 2023, Japan will host the G7 Summit in Hiroshima, the “City of Peace.” Ahead of the Summit, JCIE has established the Hiroshima G7 Global Health Task Force under the Executive Committee on Global Health and Human Security (Chairman: Keizo Takemi, Member of the House of Councillors; Executive […]
This piece by JCIE/USA Executive Director Kazuyo Kato highlights the significant of Japan’s recent pledge to the Global Fund, made at TICAD8.
This piece by JCIE Senior Fellow Jim Gannon and Friends of the Global Fight Chief Policy Officer Mark Lagon highlights the history of US-Japan collaboration on health, and how the two countries can continue creating more sustainable and equitable health systems.
The Executive Committee on Global Health and Human Security is a unique public-private platform that facilitates the Japanese government’s policymaking on global health and public-private collaboration in that field.
Ahead of the G7 Summit, JCIE has established the 2023 G7 Global Health Task Force under the Executive Committee on Global Health and Human Security to make recommendations to the Japanese government on the G7 agenda and concrete measures to be promoted for global health in the context of the rapidly changing global health architecture.
JCIE’s Global Health and Human Security Program offers a comprehensive, multistakeholder approach to promoting greater understanding, awareness, and support of global health and human security, and explores ways in which Japan and other countries can turn commitments into actions.
With just 10 more years until the Sustainable Development Goals’ (SDG) target year of 2030, there is a pressing need for Japan to increase the development impact of its global health assistance and make global health funding more strategic. This commission aims to reassess how to utilize Japan’s ODA in a more strategic manner to advance global health, adapt to structural shifts in the development field, and increase the efficacy and impact of its funding.
In 2018, JCIE’s Executive Committee on Global Health and Human Security created a Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia. The group, comprised of 15 experts from industry, academia, and government, seeks to formulate recommendations on how Japan could improve access to pharmaceuticals and medical devices in Asia.
JCIE has teamed up with the UN Foundation and the WHO Foundation as the Japan partner of the COVID-19 Solidarity Response Fund for WHO. This fund enables Japanese companies, organizations, and individuals to donate to support the work of the WHO, CEPI, UNICEF, WFP, and other international organizations in their fight against the pandemic.
FGFJ Publications | Launching a Pandemic Financing Facility: Three Proposals & Their Implications for the Global Fund
This Friends of the Global Fund, Japan publication documents proposed reforms to financing facilities for the Global Fund, with JCIE Senior Fellow Jim discussing the significance of these proposals for the Global Fund.